Revenue
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cellectis S.A. (CLLS)
Price$3.24Cached quote
Net income
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.9M | $41.5M | $755,000 | $19.2M | $30.3M | $51.1M | $15.2M | $12.7M | $25.2M | $44.8M | $55.9M | $35.2M |
| Gross profit | $72.9M | $41.5M | $18,000 | $17.4M | $28.5M | $49.1M | $3.8M | $10.0M | $22.6M | — | — | — |
| Gross margin | 100.00% | 100.00% | 2.38% | 90.76% | 93.92% | 96.18% | 25.00% | 78.49% | 89.60% | — | — | — |
| Research & development | $93.5M | $90.5M | $87.6M | $97.5M | $117.8M | $77.0M | $92.0M | $76.6M | $79.2M | $78.5M | $58.2M | — |
| Operating expenses | $106.0M | $108.8M | $106.5M | $115.4M | $142.1M | $101.9M | $146.5M | $126.5M | $126.4M | $123.7M | $93.5M | $42.1M |
| Operating income | −$33.1M | −$59.6M | −$97.3M | −$89.7M | −$103.5M | −$42.3M | −$123.6M | −$105.1M | −$92.7M | −$67.3M | −$31.0M | −$7.0M |
| Operating margin | −45.34% | −143.49% | −12,887.68% | −467.72% | −340.99% | −82.87% | −813.38% | −825.47% | −367.83% | −150.20% | −55.46% | −19.83% |
| EBITDA | −$13.0M | −$39.7M | −$78.8M | −$71.2M | −$95.9M | −$32.5M | −$116.7M | −$102.7M | −$89.3M | −$65.1M | −$29.0M | — |
| EBITDA margin | −17.84% | −95.67% | −10,434.30% | −371.56% | −316.02% | −63.64% | −768.12% | −806.80% | −354.45% | −145.27% | −52.00% | — |
| Net income | −$67.6M | −$36.8M | −$108.4M | −$114.0M | −$125.1M | −$97.5M | −$115.2M | −$88.3M | −$103.7M | −$67.3M | −$22.6M | −$1.3M |
| Net profit margin | −92.66% | −88.57% | −14,363.31% | −594.83% | −412.25% | −190.93% | −758.47% | −693.84% | −411.64% | −150.10% | −40.47% | −3.68% |
| Basic EPSper basic share | -$0.67 | -$0.41 | -$1.77 | -$2.33 | -$2.55 | -$1.91 | -$2.41 | -$1.93 | -$0.00 | -$0.00 | -$0.00 | — |
| Diluted EPSper diluted share | -$0.67 | -$0.41 | -$1.77 | -$2.33 | -$2.55 | -$1.91 | -$2.41 | -$1.93 | -$0.00 | -$0.00 | -$0.00 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
B Group, Inc. | 3.28M |
Long Focus Capital Management, LLC | 2.74M |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2.64M |
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 226.88K |
BlackRock, Inc. | 225.44K |
MORGAN STANLEY | 85.46K |
LPL Financial LLC | 84.42K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50.45K |
BNP PARIBAS FINANCIAL MARKETS | 40.1K |
UBS Group AG | 33.93K |
Delaney Dennis R | 24K |
RHUMBLINE ADVISERS | 14.33K |
XTX Topco Ltd | 12.28K |
HARBOUR INVESTMENTS, INC. | 4.5K |
NATIONAL BANK OF CANADA /FI/ | 3.6K |
WELLS FARGO & COMPANY/MN | 3.15K |
ROYAL BANK OF CANADA | 1.56K |
Atlantic Union Bankshares Corp | 1.5K |
Allworth Financial LP | 500 |
POM Investment Strategies, LLC | 495 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data